Janet Pavese

665 total citations
15 papers, 453 citations indexed

About

Janet Pavese is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Janet Pavese has authored 15 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Janet Pavese's work include Barrier Structure and Function Studies (5 papers), Cancer Research and Treatments (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Janet Pavese is often cited by papers focused on Barrier Structure and Function Studies (5 papers), Cancer Research and Treatments (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Janet Pavese collaborates with scholars based in United States, Japan and Italy. Janet Pavese's co-authors include Raymond C. Bergan, Rebecca Farmer, Irene Ogden, Borko Jovanovic, Li Xu, Xiaoke Huang, Maria Matsangou, Kohei Shitara, Manish A. Shah and Ran Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Janet Pavese

14 papers receiving 440 citations

Peers

Janet Pavese
Omar Rahal United States
Charles YF Young United States
Suzanne F. Shoemaker United States
B Zalewski Poland
J. Wahler United States
Xinshu Dong China
Shan Zhao China
Amanda B. Parris United States
Mikehl S. Hafner United States
Mu-Xin Wei China
Omar Rahal United States
Janet Pavese
Citations per year, relative to Janet Pavese Janet Pavese (= 1×) peers Omar Rahal

Countries citing papers authored by Janet Pavese

Since Specialization
Citations

This map shows the geographic impact of Janet Pavese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Pavese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Pavese more than expected).

Fields of papers citing papers by Janet Pavese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Pavese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Pavese. The network helps show where Janet Pavese may publish in the future.

Co-authorship network of co-authors of Janet Pavese

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Pavese. A scholar is included among the top collaborators of Janet Pavese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Pavese. Janet Pavese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shitara, Kohei, Farshid Dayyani, Shahwar Kazmi, et al.. (2025). 2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial. Annals of Oncology. 36. S1121–S1121.
2.
Tang, Mei, Amit Garg, Peter L. Bonate, et al.. (2024). Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors. Clinical Pharmacokinetics. 63(4). 423–438. 25 indexed citations
3.
Yang, Jianning, Akihiro Yamada, Samuel J. Klempner, et al.. (2024). Clinical pharmacology profile of the claudin 18.2 antibody zolbetuximab.. Journal of Clinical Oncology. 42(3_suppl). 316–316. 3 indexed citations
4.
Shitara, Kohei, Rui‐Hua Xu, Jaffer A. Ajani, et al.. (2024). Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Gastric Cancer. 27(5). 1058–1068. 21 indexed citations
5.
Moran, Diarmuid, Abraham Guerrero, Jung Wook Park, et al.. (2023). Prevalence of claudin 18.2 (CLDN18.2) and the association of biomarkers with clinical activity in patients with gastric or gastroesophageal adenocarcinoma (G/GEJa) treated with zolbetuximab.. Journal of Clinical Oncology. 41(4_suppl). 466–466. 2 indexed citations
6.
7.
Lee, Keun‐Wook, Samuel J. Klempner, Jianning Yang, et al.. (2021). Effect of ethnicity and chemotherapy (mFOLFOX6) on zolbetuximab pharmacokinetics in patients with claudin 18.2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ).. Journal of Clinical Oncology. 39(15_suppl). e16078–e16078. 2 indexed citations
8.
Pavese, Janet, Irene Ogden, Xiaoke Huang, et al.. (2014). Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4) Promotes Human Prostate Cancer Metastasis. PLoS ONE. 9(7). e102289–e102289. 35 indexed citations
9.
Ogden, Irene, et al.. (2014). Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5(9). 2648–2663. 43 indexed citations
10.
Pavese, Janet, et al.. (2014). Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. American Journal of Clinical Nutrition. 100. 431S–436S. 76 indexed citations
11.
Pavese, Janet & Raymond C. Bergan. (2014). Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352(2). 179–186. 28 indexed citations
12.
Pavese, Janet, Irene Ogden, & Raymond C. Bergan. (2013). An Orthotopic Murine Model of Human Prostate Cancer Metastasis. Journal of Visualized Experiments. e50873–e50873. 21 indexed citations
13.
Pavese, Janet, Irene Ogden, & Raymond C. Bergan. (2013). An Orthotopic Murine Model of Human Prostate Cancer Metastasis. Journal of Visualized Experiments. 8 indexed citations
14.
Pavese, Janet, Rebecca Farmer, & Raymond C. Bergan. (2010). Inhibition of cancer cell invasion and metastasis by genistein. Cancer and Metastasis Reviews. 29(3). 465–482. 175 indexed citations
15.
Xu, Li, Rebecca Farmer, Xiaoke Huang, et al.. (2010). Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype. Cancer Prevention Research. 3(12_Supplement). B58–B58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Rahal Breakdown of academic impact, for papers by Charles YF Young Breakdown of academic impact, for papers by Suzanne F. Shoemaker Breakdown of academic impact, for papers by B Zalewski Breakdown of academic impact, for papers by J. Wahler Breakdown of academic impact, for papers by Xinshu Dong Breakdown of academic impact, for papers by Shan Zhao Breakdown of academic impact, for papers by Amanda B. Parris Breakdown of academic impact, for papers by Mikehl S. Hafner Breakdown of academic impact, for papers by Mu-Xin Wei
Rankless by CCL
2026